Terug
Dagbereik
€ 4,99
€ 5,29
52-Weeksbereik
€ 1,33
€ 6,88
Volume
1.612.171
50D / 200D Gem.
€ 5,90
/
€ 4,29
Vorige Slotkoers
€ 5,15
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -10,5 | 0,4 |
| P/B | 3,5 | 2,9 |
| ROE % | -41,3 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 11,00
+118.3%
Low: € 9,00
High: € 15,00
Forward WPA
-€ 0,40
Omzet Sch.
1,3 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,17
-€ 0,25 – € 4,04
|
650 M | 12 |
| FY2029 |
€ 0,51
-€ 0,11 – € 1,75
|
400 M | 8 |
| FY2028 |
-€ 0,06
-€ 1,73 – € 0,85
|
190 M | 14 |
Belangrijkste Punten
Debt/Equity of 0,05 — conservative balance sheet
Negative free cash flow of -49,17M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-41,29%
ROIC-26,44%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,05
Current Ratio15,02
Interest Coverage0,00
Waardering
P/E Ratio
-10,48
P/B Ratio3,54
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -66,49M |
| ROE | -41,29% | ROA | -30,28% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -49,17M |
| ROIC | -26,44% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,05 | Current Ratio | 15,02 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -10,48 | P/B Ratio | 3,54 |
| P/S Ratio | N/A | PEG Ratio | -0,76 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 696,96M | Enterprise Value | 676,15M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 850.000,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -66,49M | -49,38M | -42,49M | -39,23M | -82,18M |
| EPS (Diluted) | -0,42 | -0,36 | -0,33 | -0,35 | -1,31 |
| Gross Profit | 0,0 | 850.000,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -72,84M | -56,63M | -50,36M | -41,66M | -81,88M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 219,59M | 140,40M | 156,88M | 199,65M | 153,76M |
| Total Liabilities | 22,80M | 15,17M | 8,34M | 18,01M | 13,68M |
| Shareholders' Equity | 196,79M | 125,23M | 148,54M | 181,64M | 140,08M |
| Total Debt | 9,83M | 6,63M | 1,73M | 2,94M | 4,04M |
| Cash & Equivalents | 30,64M | 43,48M | 24,23M | 34,95M | 144,51M |
| Current Assets | 209,82M | 132,75M | 153,88M | 194,79M | 147,11M |
| Current Liabilities | 13,97M | 8,87M | 7,80M | 16,17M | 10,63M |